Advertisement

Topics

US FDA’s Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details

10:35 EDT 13 Jun 2018 | SCRIP

Internal group headed by Principal Deputy Commissioner Rachel Sherman will develop implementation recommendations, which could include new guidance, regulations, a...

      

Related Stories

 

Original Article: US FDA’s Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details

NEXT ARTICLE

More From BioPortfolio on "US FDA’s Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details"

Advertisement
Quick Search
Advertisement
Advertisement